hVIVO (LON:HVO) Stock Price Up 10% – What’s Next?

Shares of hVIVO plc (LON:HVO) shot up 10% during trading on Monday . The company traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares changed hands during mid-day trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).

hVIVO Price Performance

The stock has a market cap of £144.58 million, a P/E ratio of 708.33 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16. The business’s fifty day moving average price is GBX 20.36 and its 200 day moving average price is GBX 25.73.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.